Median Technologies SA (EPA:ALMDT)

Market Cap	43.19M
Revenue (ttm)	22.96M
Net Income (ttm)	-25.24M
Shares Out	19.90M
EPS (ttm)	-1.37
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	151,829
Average Volume	299,246
Open	2.170
Previous Close	2.135
Day's Range	2.075 - 2.225
52-Week Range	1.190 - 7.760
Beta	0.77
RSI	54.07
Earnings Date	Sep 16, 2025

About Median Technologies

Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device for early diagnosis of cancers and fibrotic diseases; iSee for image analysis services in clinical trials; and iCRO, which engages in the sale of imaging services for clinical trials in oncology using software. The company was founded in 2002 and is based in Valbonne, ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 225
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALMDT

Financial Performance

In 2024, Median Technologies's revenue was 22.96 million, an increase of 0.79% compared to the previous year's 22.78 million. Losses were -25.24 million, 9.83% more than in 2023.